Press Release
GE healthcare LAUNCHES NEW LAPTOP-SIZE ULTRASOUND DESIGNED FOR
WOMEN’S HEALTHCARE AT ACOG 2007
Also at ACOG, GE Highlights Enhanced Features of Voluson i Breakthrough
2007, Versatility of LOGIQ P5 for OB/GYN Exams, and Improved Ultrasound
Data Management with ViewPoint 2007
SAN DIEGO, MAY 7, 2007 -- GE Healthcare launches today the Voluson e
system, a compact ultrasound system designed specifically for
women’s healthcare, including obstetric, gynecological, and
other clinical applications. The portability of this
approximately 11-pound system can provide high-quality imaging at the
patient bedside and for community clinics, where space constraints are
possible. This new compact system, on the heels of last
year’s launch of the Voluson i, also allows clinicians to
make real-time diagnoses, particularly for high-risk patients. The
Voluson e is being showcased May 7-9 in GE Healthcare’s booth
#1523 in exhibit halls C-H, at the 55th Annual Clinical Meeting of the
American College of Obstetricians and Gynecologists (ACOG) in San Diego.
The Voluson e is specifically designed for uses in labor and delivery,
gynecological exams and studies and assisted reproductive medicine.
According to Omar Ishrak, president and CEO of GE
Healthcare’s Clinical Systems business, there is a need for
more specialized, high-quality point of care systems to meet the
growing demands for on-the-spot diagnosis. “The Voluson e and
Voluson i address one of the biggest challenges OB/GYN physicians face
in caring for their high-risk patients – access to complete,
real-time information that allows them to make clinical decisions at
the patient’s bedside with confidence,” Ishrak said.
Other GE products showcased at ACOG include:
Voluson i Breakthrough 2007 – The Voluson i Breakthrough 2007
makes its debut at ACOG. The enhanced features offer clinically
relevant enhancements to help improve patient care. A wider breadth of
tools helps allow clinicians to stay at the forefront of
women’s healthcare and better assess patients for volumetric
ultrasound studies, such as assessing the fetal heart. Migrating
advanced technologies across the Voluson product line is the
underpinning of this annual GE Breakthrough release. Each
“i” product is designed to bring specialized,
console-quality imaging performance and portability to traditional
applications. GE’s Compact Series
“e” products focus on expanding
ultrasound’s reach to new clinical areas.
LOGIQ P5 – The LOGIQ P5, introduced in 2006, has never been
seen before at ACOG. The LOGIQ P5 is part of the radiology
line of LOGIQ ultrasound systems and provides versatility to clinics.
From fibroid and cystic structure visualization, to routine fetal
measurements and advanced applications, this system helps image
patients for a clinic’s women’s healthcare
specialty. GE’s TruScan™ architecture provides
advanced diagnostic tools to provide better penetration and contrast
resolution. Features such as Phase Inversion Harmonics help deliver
clear border definition for improved visualization of the endometrial
lining and clearer tumor assessments.
ViewPoint 2007 – The next generation of this comprehensive
ultrasound data management solution for OB/GYN practices, launched at
AIUM 2007, combines reporting and image archiving, while aiding
clinicians in making their ultrasound workflow quicker and easier.
Features to help improve workflow include image comparison, and
integrated 4D View version 6.0 for post processing of Voluson E8 and
Voluson 730 images. Reporting improvements include the fetal anatomy
overview and a single fetal anatomy report screen based on AIUM
guidelines for extended second trimester fetal scan. Other improvements
included in ViewPoint 2007 are enhanced document management, PDF export
and improved document history functionality.
ABOUT GE HEALTHCARE
GE Healthcare provides transformational medical technologies and
services that are shaping a new age of patient care. Our expertise in
medical imaging and information technologies, medical diagnostics,
patient monitoring systems, performance improvement, drug discovery,
and biopharmaceutical manufacturing technologies is helping clinicians
around the world re-imagine new ways to predict, diagnose, inform,
treat and monitor disease, so patients can live their lives to the
fullest.
GE Healthcare's broad range of products and services enable healthcare
providers to better diagnose and treat cancer, heart disease,
neurological diseases and other conditions earlier. Our vision for the
future is to enable a new "early health" model of care focused on
earlier diagnosis, pre-symptomatic disease detection and disease
prevention. Headquartered in the United Kingdom, GE Healthcare is a $17
billion unit of General Electric Company (NYSE: GE). Worldwide, GE
Healthcare employs more than 46,000 people committed to serving
healthcare professionals and their patients in more than 100 countries.
For more information about GE Healthcare, visit our website at
www.gehealthcare.com.
Media Contact:
GE Healthcare
Carrie Michael
T: 414-721-2631
C: 262-501-2909
carrie.michael@ge.com